[This corrects the article DOI: 10.1016/j.isci.2021.102427.].

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8661465PMC
http://dx.doi.org/10.1016/j.isci.2021.103335DOI Listing

Publication Analysis

Top Keywords

erratum myeloid
4
myeloid nrf2
4
nrf2 deficiency
4
deficiency aggravates
4
aggravates non-alcoholic
4
non-alcoholic steatohepatitis
4
steatohepatitis progression
4
progression regulating
4
regulating yap-mediated
4
yap-mediated nlrp3
4

Similar Publications

Corrigendum to "Co-Delivery of Daunorubicin and Homoharringtonine in Folic Acid Modified-Liposomes for Enhancing Therapeutic Effect on Acute Myeloid Leukemia" [Journal of Pharmaceutical Sciences Volume 112 (2023) 123-131].

J Pharm Sci

December 2024

Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province, Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology, West China School of Pharmacy, Sichuan University, Chengdu 610041, China.. Electronic address:

View Article and Find Full Text PDF
Article Synopsis
  • The text addresses a correction made to a scientific article, specifically referring to its DOI (Digital Object Identifier) number, which is a unique identifier for academic papers.
  • The correction aims to clarify information or errors previously published in the original article.
  • The DOI provided, 10.3389/fimmu.2024.1403155, points to this specific article in the Frontiers in Immunology journal.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!